It's been one year since NEA, in collaboration with four peer patient advocacy organizations, hosted the landmark patient-focused drug development (PFDD) meeting dedicated to eczema.
Published On: Jun 20, 2016
Last Updated On: Jun 20, 2016
This past January, many of you responded an online survey to evaluate patient satisfaction and the role of doctors in the treatment of the most serious form of eczema, atopic dermatitis. We learned that the vast majority of participants:
The results of this survey are called patient reported outcomes. That is, information given by patients on their experience with having a particular disease or set of symptoms. Understanding the patient experience provides critical information to physicians, health insurance companies, government agencies (such as the FDA or CDC), drug manufacturers, clinical researchers, and even patients on how to manage their condition.